美國NovaBios埃博拉病毒診斷試劑（剛果）

廣州健侖生物科技有限公司

本司長期供應埃博拉病毒檢測試劑盒，其主要品牌包括美國NovaBios、廣州創侖等CDC使用的進口產品，試劑盒的實驗方法包括膠體金方法、ELISA方法、PCR方法等。

歡迎咨詢

歡迎咨詢2042552662

埃博拉病毒IgM、IgG、ELISA檢測試劑、埃博拉快速檢測試劑盒、

埃博拉病毒核酸檢測試劑盒（熒光探針PCR）

西非工作、旅游埃博拉檢測試劑盒

美國CDC使用的埃博拉診斷試劑——美國的NovaBios

美國NovaBios 埃博拉病毒診斷試劑（剛果）

【埃博拉簡介】

埃博拉（Ebola virus）又譯作伊波拉病毒。是一種十分罕見的病毒，1976年在蘇丹南部和剛果（金）（舊稱扎伊爾）的埃博拉河地區發現它的存在后，引起醫學界的廣泛關注和重視，“埃博拉”由此而得名。是一個用來稱呼一群屬于纖維病毒科埃博拉病毒屬下數種病毒的通用術語。是一種能引起人類和靈長類動物產生埃博拉出血熱的烈性傳染病病毒，有很高的死亡率，在50%至90%之間，致死原因主要為中風、心肌梗塞、低血容量休克或多發性器官衰竭。

埃博拉出血熱（EBHF）是由一種絲狀病毒感染導致的急性出血性、動物源性傳染病。1976年，埃博拉出血熱在非洲的蘇丹和扎伊爾暴發，病死率高達50% ～ 90% 。因該病始發于扎伊爾北部的埃博拉河流，并在該區域嚴重流行，故命名為埃博拉病毒，其形態學、致病性等與馬爾堡病毒相似，但免疫原性有所區別。

【產品介紹】

該產品是世界衛生組織（WHO）*個批準用于埃博拉病毒檢測的診斷試劑卡。不需要借助其他實驗儀器設備，只需要采取幾滴血清、血漿、血液樣品，既可以檢測，并在15分鐘內就可以得知結果是否感染埃博拉病毒。該產品具有靈敏度高、操作方便、實驗時間短等特點。

美國NovaBios

正在西非乃至 肆虐的埃博拉病毒，有著*的高致死率。在以往 的爆發中，高達90%的被感染者死于埃博拉。和本次大爆發同宗的扎伊爾型埃博拉病毒以往平均死亡率為80%。這也是為什么，世界衛生組織疫情報告中的數據看起來有那么一丁點像好消息—— 盡管埃博拉感染率正在以驚人的速度攀升，報告中整體死亡率卻只有53%，從塞拉利昂的39%到幾內亞的64%。這比以往幾次疫情爆發要相對溫和一點。難道是這次爆發的病毒比以往的致死率與危害性低一點?還是說我們已經有了更有效的治療方案?
　　實際上此處有一個隱情：明顯降低的死亡率可能更多是因為*測算方式的緣故，而非病毒的致死率，或者說患者接受的治療水平導致的。事實上，zui近幾周感染人數的急劇增加，正是報告死亡率看起來不那么高的其中一個主要原因。
　　*所謂的死亡率，或者說一個爆發疾病的“病死率”，有若干計算方式。其中zui為簡單的，就是目前死亡人數除以目前總感染人數。世界衛生組織zui近報告的死亡率也就是這樣計算的。
　　但是這種方法并沒有考慮到，許多依然存活的病人——特別是剛剛被診斷又病得很厲害的——很可能也不能活下來。因此這低估了實際死亡率。特別是疾病在快速擴張時，這種低估效應會被加大。來自英國愛丁堡大學研究傳染病的進化生物學家Andrew Rambaut認為，這種計算也忽視了那些被確診為埃博拉感染者，卻在被批準恢復并出院之前已經離開醫院的患者的生死。許多這樣的病人后來都死了，但是卻沒有被統計在*死亡數據中。
　　另一種計算方式是只考慮已經確認恢復而不再需要治療與已經死于疾病的患者，而不計入目前還在治療中的病人。這樣的結果看起來更為克制精確。根據11月5號塞拉利昂健康與衛生部疫情報告，841個確診病人被治療后出院了，而1,103個確診病人已經過世。這樣該地的埃博拉死亡率應該是57%，而非世界衛生組織報告的39%。不過來自哈佛公共衛生學院的流行病學專家Marc Lipsitch認為，這樣的計算方式依然不夠準確。治愈出院的病人通常比死于病癥的病人，要在醫院待更長的時間。也就是說不計入計算的還在治療中的病人，實際上是更可能治愈的那批。因此這樣的計算會高估實際死亡率。

美國NovaBios

我司還提供其它進口或國產試劑盒：登革熱、瘧疾、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團菌等試劑盒以及日本生研細菌分型診斷血清、德國SiFin診斷血清、丹麥SSI診斷血清等產品。

想了解更多的NovaBios產品及服務請掃描下方二維碼：

【公司名稱】 廣州健侖生物科技有限公司
【市場部】    楊永漢

【】 
【騰訊  】 2042552662
【公司地址】 廣州清華科技園創新基地番禺石樓鎮創啟路63號二期2幢101-103室

The Ebola virus, which is raging in West Africa and the world, has a well known high lethality. In the past, up to 90% of the infected people died in Ebola. And the outbreak of the same case of Zaire-type Ebola virus in the past the average mortality rate of 80%. That's why the data in the latest WHO report looks so good news - despite the fact that the Ebola infection rate is climbing at an alarming rate, the overall mortality rate in the report is only 53 per cent, from the Sierra Leone 39% to 64% of Guinea. This is relatively mild than the previous outbreak of the epidemic. Is it the outbreak of the virus than the previous lethality and harm lower? Or that we have a more effective treatment program?
In fact there is a hidden situation here: the apparent reduction in mortality may be more due to the official method of measurement, rather than the mortality rate of the virus, or the level of treatment received by the patient. In fact, the sharp increase in the number of infections in recent weeks is one of the main reasons for reporting that mortality is not so high.
The official so-called mortality rate, or an outbreak of the disease "mortality", there are a number of ways to calculate. One of the most simple is the current number of deaths divided by the current total number of infections. The World Health Organization's recently reported mortality rate is calculated as such.
But this approach does not take into account that many surviving patients - especially those who have just been diagnosed and ill - are likely to survive. So this underestimates the actual mortality rate. Especially in the rapid expansion of the disease, this underestimated effect will be increased. Andrew Rambaut, an evolutionary biologist at the University of Edinburgh who studies infectious diseases in the UK, believes that this calculation also ignores the life and death of patients who have been diagnosed with Ebola infection but who have left the hospital before being approved for recovery and discharge. Many of these patients were later dead, but they were not counted in official death data.
Another way is to consider only patients who have confirmed recovery and no longer need treatment and who have died of the disease, regardless of the patients who are still in the process of treatment. This result seems to be more restrained. According to the latest epidemic report of the Ministry of Health and Health in Sierra Leone on November 5, 841 confirmed patients were discharged after treatment and 1,103 confirmed patients had passed away. So that the Ebola death rate should be 57%, rather than 39% of the World Health Organization reported. However, from the Harvard School of Public Health epidemiologist Marc Lipsitch that this calculation is still not accurate enough. Cure patients are usually discharged longer than the patient who died of the illness and had to stay in the hospital for a longer period of time. That is, do not count into the calculation of the patients still in the treatment, in fact, is more likely to cure the batch. So this calculation will overestimate the actual mortality rate.